|
[1]
|
王同成, 唐元升. 急性冠脉综合征的研究进展[J]. 山东医药, 2004, 44(31): 68-69.
|
|
[2]
|
乌云嘎, 魏君, 常宏, 等. LP-PLA2: 预测心血管疾病的新兴标志物[J]. 中国实验诊断学, 2022, 26(9): 1417-1419.
|
|
[3]
|
Roffi, M., Patrono, C., Collet, J.P., et al. (2016) 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Pre-senting without Persistent ST-Segment Elevation: Task Force for the Management of Acute Coronary Syndromes in Pa-tients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal, 37, 267-315. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Collet, J.P., Thiele, H., Barbato, E., et al. (2021) 2020 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persis-tent ST-Segment Elevation. European Heart Journal, 42, 1289-1367.
|
|
[5]
|
中国医师协会急诊医师分会, 国家卫健委能力建设与继续教育中心急诊学专家委员会, 中国医疗保健国际交流促进会急诊急救分会. 急性冠脉综合征急诊快速诊治指南(2019) [J]. 临床急诊杂志, 2019, 20(4): 253-262.
|
|
[6]
|
Mueller, C., Giannitsis, E., Christ, M., et al. (2016) Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction with High-Sensitivity Cardiac Troponin T. Annals of Emergency Medicine, 68, 76-87.e4.
|
|
[7]
|
Dalal, J.J., Ponde, C.K., Pinto, B., et al. (2016) Time to Shift from Contemporary to High-Sensitivity Cardiac Troponin in Diagnosis of Acute Coronary Syndromes. Indian Heart Journal, 68, 851-855. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Claeys, M.J. (2014) High-Sensitivity Troponin: Does It Predict the Shape of the Iceberg Underneath the Surface? European Heart Journal, 35, 2273-2275. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Thiele, H. and Jobs, A. (2021) ESC Guidelines 2020: Acute Coro-nary Syndrome without Persistent ST-Segment Elevation: What Is New? Herz, 46, 3-13.
|
|
[10]
|
Apple, F.S., Collinson, P.O., Kavsak, P.A., et al. (2021) Getting Cardiac Troponin Right: Appraisal of the 2020 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment El-evation by the International Federation of Clinical Chemistry and Laboratory Medicine Committee on Clinical Applica-tions of Cardiac Bio-Markers. Clinical Chemistry, 67, 730-735. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Kienbacher, C.L., Fuhrmann, V., van Tulder, R., et al. (2021) Im-pact of More Conservative European Society of Cardiology Guidelines on the Management of Patients with Acute Chest Pain. International Journal of Clinical Practice, 75, e14133. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Szarpak, L., Lapinski, M., Gasecka, A., et al. (2021) Performance of Copeptin for Early Diagnosis of Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of 14,139 Patients. Journal of Cardiovascular Development and Disease, 9, Arti-cle 6. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
边美琪, 马根山. 急性冠脉综合征生物标志物的研究[J]. 现代医学, 2017, 45(1): 157-162.
|
|
[14]
|
Da Molin, S., Cappellini, F., Falbo, R., Signorini, S. and Brambilla, P. (2014) Verifi-cation of an Immunoturbidimetric Assay for Heart-Type Fatty Acid-Binding Protein (H-FABP) on a Clinical Chemistry Platform and Establishment of the Upper Reference Limit. Clinical Biochemistry, 47, 247-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Agnello, L., Bivona, G., Novo, G., et al. (2017) Heart-Type Fatty Acid Binding Protein is a Sensitive Biomarker for Early AMI Detection in Troponin Negative Patients: A Pilot Study. Scandinavian Journal of Clinical and Laboratory Investigation, 77, 428-432. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Goel, H., Melot, J., Krinock, M.D., et al. (2020) Heart-Type Fatty Acid-Binding Protein: An Overlooked Cardiac Biomarker. Annals of Medicine, 52, 444-461. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Kellens, S., Verbrugge, F.H., Vanmechelen, M., et al. (2016) Point-of-Care Heart-Type Fatty Acid Binding Protein versus High-Sensitivity Troponin T Testing in Emergency Patients at High Risk for Acute Coronary Syndrome. European Heart Journal. Acute Cardiovascular Care, 5, 177-184. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Schoenenberger, A.W., Stallone, F., Walz, B., et al. (2016) In-cremental Value of Heart-Type Fatty Acid-Binding PRotein in Suspected Acute Myocardial Infarction Early after Symp-tom Onset. European Heart Journal. Acute Cardiovascular Care, 5, 185-192. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Ndrepepa, G. (2019) Myeloperoxidase—A Bridge Linking In-flammation and Oxidative Stress with Cardiovascular Disease. Clinica Chimica Acta, 493, 36-51. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Chaikijurajai, T. and Tang, W.H.W. (2020) Myeloperoxidase: A Potential Therapeutic Target for Coronary Artery Disease. Expert Opinion on Therapeutic Targets, 24, 695-705. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Li, J., Cao, T., Wei, Y., et al. (2021) A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (sST2), Lipopro-tein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT). Disease Markers, 2021, Article ID: 6258865. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Chen, W., Tumanov, S., Kong, S.M.Y., et al. (2022) Therapeutic Inhibition of MPO Stabilizes Pre-Existing High Risk Atherosclerotic Plaque. Redox Biology, 58, Article ID: 102532. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
赵倩, 陈还珍. 髓过氧化物酶在心血管疾病中作用的研究进展[J]. 中西医结合心脑血管病杂志, 2022, 20(6): 1021-1024.
|
|
[24]
|
Mehta, M.D., Marwah, S.A., Ghosh, S., et al. (2016) A Synergistic Role of Myeloperoxidase and High Sensitivity Troponin T in the Early Diagnosis of Acute Coronary Syndrome. Indian Journal of Clinical Biochemistry, 31, 75-80. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Kolodziej, A.R., Abo-Aly, M., Elsawalhy, E., et al. (2019) Prog-nostic Role of Elevated Myeloperoxidase in Patients with Acute Coronary Syndrome: A Systemic Review and Me-ta-Analysis. Mediators of Inflammation, 2019, Article ID: 2872607. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Frangie, C. and Daher, J. (2022) Role of Myeloperoxidase in Inflam-mation and Atherosclerosis (Review). Biomedical Reports, 16, Article No. 53. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
薄磊, 单既刚, 赵志文. 心血管疾病中髓过氧化物酶的研究进展[J]. 检验医学, 2017, 32(8): 738-743.
|
|
[28]
|
王志谦, 汪晶彩. 脂蛋白相关磷脂酶A2在心血管疾病中的相关进展[J]. 心血管病学进展, 2017, 38(6): 703-706.
|
|
[29]
|
Acar, T., Koçak, S., Cander, B., et al. (2016) Liporotein-Associated Phos-pholipase-A2 Can Be a Diagnostic Marker in the Early Stage Diagnosis of Acute Mesenteric Ischemia. Turkish Journal of Medical Sciences, 46, 120-125. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Cen, J.M., Cheng, J., Xiong, Q.Y., et al. (2015) Study on the Correlation between the Concentration of Plasma Lipoprotein-Associated Phospholipase A2 and Coronary Heart Disease. Chronic Diseases and Translational Medicine, 1, 105-109. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Zhang, H., Gao, Y., Wu, D. and Zhang, D.G. (2020) The Relationship of Lipoprotein-Associated Phospholipase A2 Activity with the Se-riousness of Coronary Artery Disease. BMC Cardiovascular Disorders, 20, Article No. 295. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
方顺淼, 葛兴利, 李运田, 等. 脂蛋白相关磷脂酶A2和心型脂肪酸结合蛋白诊断急性心肌梗死的价值及与预后的关系[J]. 中华老年心脑血管病杂志, 2022, 24(2): 148-150.
|
|
[33]
|
中国医师协会急诊医师分会, 国家卫健委能力建设与继续教育中心急诊学专家委员会, 中国医疗保健国际交流促进会急诊急救分会. 急性冠脉综合征急诊快速诊治指南(2019) [J]. 临床急诊杂志, 2019, 20(4): 253-262.
|
|
[34]
|
Yang, L., Liu, Y., Wang, S.F., Liu, T. and Cong, H.L. (2017) Association between Lp-PLA2 and Coro-nary Heart Disease in Chinese Patients. Journal of International Medical Research, 45, 159-169. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Zhang, M.M., Zhang, C.G., Yang, C.J., Zhao, P. and Li, Y.L. (2019) The Association between the D166E Polymorphism of the Lipoprotein Associated Phospholipase A2 and Risk of Myocardial Infarction. European Review for Medical and Pharmacological Sciences, 23, 3960-3966.
|
|
[36]
|
Sebbane, M., Lefebvre, S., Kuster, N., et al. (2013) Early Rule Out of Acute Myocardial Infarction in ED Patients: Value of Combined High-Sensitivity Cardiac Troponin T and Ultrasensitive Copeptin Assays at Admission. The American Journal of Emer-gency Medicine, 31, 1302-1308. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Giannitsis, E., Slagman, A., Hamm, C.W., et al. (2020) Copeptin Combined with Either Non-High Sensitivity or High Sensitivity Cardiac Troponin for Instant Rule-Out of Suspected Non-ST Segment Elevation Myocardial Infarction. Biomarkers, 25, 649-658. [Google Scholar] [CrossRef]
|
|
[38]
|
Stengaard, C., Sørensen, J.T., Ladefoged, S.A., et al. (2017) The Potential of Optimizing Prehospital Triage of Patients with Suspected Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin T and Copeptin. Biomarkers, 22, 351-360. [Google Scholar] [CrossRef]
|
|
[39]
|
Kankra, M., Mehta, A., Sawhney, J.P.S., et al. (2022) Im-proving the ACS Triage-Using High Sensitivity TroponinI and Copeptin for Early ‘Rule-Out’ of AMI. Indian Journal of Clinical Biochemistry, 37, 449-457. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Giannitsis, E., Garfias-Veitl, T., Slagman, A., et al. (2022) Bi-omarkers-in-Cardiology 8 RE-VISITED—Consistent Safety of Early Discharge with a Dual Marker Strategy Combining a Normal hs-cTnT with a Normal Copeptin in Low-to-Intermediate Risk Patients with Suspected Acute Coronary Syn-drome—A Secondary Analysis of the Randomized Biomarkers-in-Cardiology 8 Trial. Cells, 11, Article 211. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Pedersen, C.K., Stengaard, C., Sondergaard, H., et al. (2018) A Multi-centre, Randomized, Controlled Open-Label Trial to Compare an Accelerated Rule-Out Protocol Using Combined Pre-hospital Copeptin and in-Hospital High Sensitive Troponin with Standard Rule-Out in Patients Suspected of Acute My-ocardial Infarction—The AROMI Trial. Trials, 19, Article No. 683. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
丘江. 高敏肌钙蛋白I联合心型脂肪酸结合蛋白在诊断早期非ST段抬高急性冠脉综合征中的意义[J]. 标记免疫分析与临床, 2021, 28(2): 240-242, 321.
|
|
[43]
|
孙雪梅, 许强, 孙晓萌, 等. 心脏疾病标志物cTnT和H-FABP联合检测微流体测试卡的开发及评价[J]. 国际检验医学杂志, 2021, 42(1): 59-63.
|